Posted by BekkaH on November 27, 2002, at 20:21:58
In reply to Re: (atomoxetine hcl) Strattera- FDA approved for ADD, posted by rytoor on November 27, 2002, at 19:32:30
> I'm wondering why this hasn't received more attention. Is it like Reboxetine and Desipramine in being NE targeted? I wonder why Lilly isn't touting it for depression, too. Thoughts?
>
***********************************************I've read that Atomoxetine is similar to reboxetine. They are both NE reuptake inhibitors, but I do not understand why Lilly wouldn't be marketing it for depression as well. Perhaps doing so would take longer for FDA approval?
poster:BekkaH
thread:129525
URL: http://www.dr-bob.org/babble/20021127/msgs/129651.html